Medtronic plc announced three-month results from an on-label, prospective, multi-center study showing meaningful pain relief using DTM SCS endurance therapy, a modified, lower-energy variation of the company's Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) therapy for chronic overall, back or leg pain.
Medtronic announced the results of an analysis on the impact of stroke severity in patients receiving its HeartWare HVAD System...
Penumbra, Inc. announced the latest STRIKE-PE data evaluating Penumbra’s Indigo Aspiration System with Lightning.
AbbVie has announced high SVR12 rates with 8 weeks of treatment with its investigational, pan-genotypic regimen of ABT 493 (glecaprevir)...
HeartWare International has announced that data from its first destination therapy clinical trial cohort, ENDURANCE, successfully demonstrated that the trial...
The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of aclidinium/formoterol (AB/FF) 400/12 μg twice daily on lung hyperinflation, exercise capacity, and physical activity in patients with moderate-to-severe COPD.
Mechanical circulatory support with a left ventricular assist device (LVAD) is an established treatment for patients with advanced heart failure.
A new comparative effectiveness analysis, published online in Wound Repair & Regeneration, reported that Apligraf, from Novartis, has demonstrated improved...